| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Sunitinib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Substance with vascular endothelial growth factor receptor antagonist mechanism of action (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Sunitinib malate (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Bevacizumab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Ranibizumab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Pegaptanib sodium (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Sorafenib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Pegaptanib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Vandetanib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Axitinib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Sorafenib tosylate (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Cabozantinib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Lenvatinib mesilate |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Pazopanib hydrochloride (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Pazopanib (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Lenvatinib |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Ramucirumab |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Regorafenib |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Aflibercept |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Brolucizumab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Cabozantinib s-malate |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|
| Faricimab (substance) |
This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. |
True |
Vascular endothelial growth factor receptor antagonist (disposition) |
Inferred relationship |
Some |
|